Upstate Active Clinical Trials
Study Title:Temozolomide with Irinotecan versus Temozolomide, Irinotecan plus Bevacizumab for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening Trial
What is the purpose of the study?Randomized treatment study to look at the effect of temozolomide & irinotecan hydrochloride together with or without bevacizumab in treating young patients with recurrent or refractory medulloblastoma or CNS primitive neuroectodermal tumors.
Upstate Institutional Review Board (IRB) Number:263526
Patient Age Group:Children
Principal Investigator:Karol H Kerr, MD
Who can I contact for more information?
Name: Beatriz Kovar